Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
This action will contribute to the implementation of lung cancer screening programmes, to enhance early detection and programme efficiency. The gradual and appropriate planning, piloting, and roll-out of the screening programs will align with national priorities and the latest scientific advancements as called for in the 2022 Council Recommendation on cancer screening. The use of AI in ongoing (pilot) programmes shall be assessed, and the potential use of AI, where feasible, further be explored. Synergies with actions implementing the European Cancer Imaging Initiative, in particular the Cancer Image Europe platform, shall be explored. Potential synergies with the project stemming out of the “Call for proposals on advancing the adoption of artificial intelligence in health” (DI-g-24-76 from the 2024 EU4Health Work Programme) shall be explored.
Detailed Call Description
The action may include the following activities:
- facilitating implementation research via new pilots and rollout initiatives through:
- monitoring and assessment of on-going implementation studies;
- defining needs for and planning of new implementation studies based on gap analyses, building on deliverables of the SOLACE project;
- supporting, coordinating and running implementation studies within Member States;
- linking regional/national implementations studies within Member States to reduce duplication and human/financial resources as well as to increase study impact;
- regular quality assessment and improvement of implementation research.
- facilitating aggregation and analysis of the cancer imaging datasets, allowing crossborder multi-centric cooperation on AI studies, including research and development of replicable AI algorithms for lung cancer screening and for strengthening the evidence base for AI uptake in lung cancer screening programmes;
- collection and assessment of benefits/harms data and other data on outcomes, quality assurance and cost-effectiveness relating to lung cancer screening programmes from the national level based on the established methods, infrastructure and networks within the previous EU4Health Programme funded projects;
- linking relevant experts and representatives from European medical societies and patient organisations to ensure broad outreach to corresponding national partner societies and patient organisations;
- effective dissemination as well as bidirectional knowledge exchange with all Member States and relevant candidate countries relating to lung cancer screening;
- close collaboration with related projects, such as those covering prostate and gastric cancer screening, and the Joint Action Implementation of cancer screening programmes (‘EUCanScreen’) from the 2023 EU4Health work programme action CR-g-23-38;
- close collaboration and alignment with the Commission’s Joint Research Centre and the outputs of the planned Commission Initiative on Lung Cancer;
- exploration of the potential of artificial intelligence (‘AI’) in lung cancer screening in synergy with the activities under the European Cancer Imaging Initiative.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
Indicative project budget: €7.400.000
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%).
You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’, i.e. concerns:
- actions where at least 30 % of the budget is allocated to Member States (or EU4H associated countries) whose GNI per inhabitant is less than 90% of the EU average or
- actions with bodies from at least 14 Member States (or EU4H associated countries) and where at least four are from Member States (or EU4H associated countries) whose GNI per inhabitant is less than 90% of the EU average.
Grants may NOT produce a profit (i.e. surplus of revenues + EU grant over costs).
For-profit organisations must declare their revenues and, if there is a profit, we will deduct it from the final grant amount.
Thematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Associations
- Central Government
- Educational Institutions
- International Organisations
- Legal Entities
- NGOs
- Non Profit Organisations
- Other Beneficiaries
- Private Bodies
- Researchers/Research Centers/Institutions
- Semi-governmental organisations
- State-owned Enterprises
Eligibility For Participation Notes
In order to be eligible, the applicants (beneficiaries and affiliated entities) must be legal entities (public or private bodies) established in EU Member States (including overseas countries and territories (OCTs)) or EEA countries and countries associated to the EU4Health Programme (list of participating countries).
For topic EU4H-2026-SANTE-PJ-02: Proposals must be submitted by a consortium of at least 5 beneficiaries from 5 different eligible countries.
Type of applicants targeted: Public authorities, research organisation, civil society organisations, ERNs, academia and education establishments, hospitals, international organisations, networks in field of health.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Telephone: 22605300/301, 22605617, 22605718
Address: Corner of Prodromou 1 & Chilonos 17 1448 Nicosia, Cyprus
Ms MAKRIGIORGI Elena
Email: emakrigiorgi@moh.gov.cy
EU Contact Point
For help related to this call, please contact: HADEA-HP-CALLS@ec.europa.eu